Haven’t done any DD in awhile but this is worth

Haven’t done any DD in awhile but this is worth a copy from another site. I know I’m pretty optimistic but I think we may have some substantial news. Approval? Not likely or maybe we are wrong the trial was stopped, NP and his crew need time to get everything together for approval.


“””This copied from Investor Village Board. (Sorry if already discussed). Explains why Leronlimab has the NIH searching for an alternate drug or two to counterattack Leronlimab.


Dr. Francis Collins NIH Dir. - Bullish on Cytokine Storm Immuno-Modulators
https://www.nih.gov/news-events/news-releases...t-covid-19

He just appeared on CNN, litterally touting Immuno-Modulator importance for reducing Covid19 mortality. Today, NIH also suddenly issues ACTIV trials for cytokine storm immuno modulators.

Clearly, they were waiting for LL data IMHO. Now that CYDY has proven LL and Covid19 immunologic MOA, ALL BP's are rushing in for a piece of the cake AND propelled by an NIH too eager to fix its lack of pandemic response and overall bias & credibility.

Unfortunately for shorties, you've all just been caught with your pants down.

Me really think, we have struck gold.

Have a great weekend to all longs and a truly wrotten one for the shorties.

Fil. rnative to Leronlimab, in my opinion only.”””